Clinical Trial Update: Efficacy of Beta-Hydroxy-Beta-Methylbutyrate (HMB) Supplementation in Hemodialysis Patients [NA]

View source ↗

Summary

A completed clinical trial evaluated the efficacy of Beta-Hydroxy-Beta-Methylbutyrate (HMB) supplementation in adults undergoing hemodialysis. The study targete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease

Drugs mentioned

• beta-hydroxy-beta-methylbutyrate (HMB) supplement (HMB)

Snippet

Sponsor: University of Illinois at Urbana-Champaign | Conditions: Complication of Dialysis, Chronic Kidney Disease | NA | Status: COMPLETED